≡ Risteys
R10

Documentation Changelog GitHub Contact & Feedback

Other abnormal uterine and caginal bleeding

MESH Endpoint Browser PheWeb

N14_ABNORMALBLEED

No definition available.

Endpoint definition

↥
FinnGen phenotype data

429209 individuals

diagram downward connector
diagram bullet

Apply sex-specific rule

Sex only females

239906

diagram downward connector

Check conditions None

239906

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 N93
Hospital discharge: ICD-9 626[7-9]
Hospital discharge: ICD-8 626[5-9]
Cause of death: ICD-10 N93
Cause of death: ICD-9 626[7-9]
Cause of death: ICD-8 626[5-9]

2 out of 7 registries used, show all original rules.

11511

diagram downward connector

Check minimum number of events None

11511

diagram downward connector

Include endpoints None

11511

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

11109

diagram downward connector
N14_ABNORMALBLEED

Control definitions

Control exclude N14_FEMALEGENNONINF

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2
Parent code in ICD-10 N80-N98
Name in latin Alia haemorrhagia abnormis uteri et vaginae

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 11109 11109 -
Unadjusted prevalence (%) 2.70 4.82 -
Mean age at first event (years) 38.94 38.94 -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.01 0.54 [0.45, 0.65] 1.3e-11 1437
15 years 0.00 0.39 [0.33, 0.46] 2.7e-29 462
5 years 0.00 0.32 [0.25, 0.41] 7.5e-20 83
1 year 0.00 0.51 [0.33, 0.79] 2.5e-3 23

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: N14_ABNORMALBLEED – Other abnormal uterine and caginal bleeding
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Other abnormal uterine and caginal bleeding
after Other abnormal uterine and caginal bleeding

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Other abnormal uterine and caginal bleeding

↥

Endpoint not on priority list, no data to show.